Prehospital administration of tenecteplase for ST-segment elevation myocardial infarction in a rural EMS system

Prehospital Emergency Care

Volumn 15, Issue 4, 2011, Pages 499-505

  Crowder, Joseph S ^a   Hubble, Michael W ^a   Gandhi, Sanjay ^b   McGinnis, Henderson ^b   Zelman, Stacie ^b   Bozeman, William ^b   Winslow, James ^b  

^a WESTERN CAROLINA UNIVERSITY   (United States)

^b WAKE FOREST BAPTIST HEALTH   (United States)

Author keywords

Emergency medical services; Myocardial infarction; Paramedic; Prehospital; Rural EMS; STEMI; Tenecteplase; Thrombolytic

Indexed keywords

FIBRINOLYTIC AGENT; TENECTEPLASE; TISSUE PLASMINOGEN ACTIVATOR;

ARTICLE; EMERGENCY HEALTH SERVICE; FEMALE; FIBRINOLYTIC THERAPY; HEART INFARCTION; HUMAN; MALE; MEDICAL RECORD; METHODOLOGY; MIDDLE AGED; OUTCOME ASSESSMENT; RETROSPECTIVE STUDY; RURAL HEALTH CARE; STANDARD; TIME; UNITED STATES;

EMERGENCY MEDICAL SERVICES; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MALE; MEDICAL RECORDS; MIDDLE AGED; MYOCARDIAL INFARCTION; NORTH CAROLINA; OUTCOME ASSESSMENT (HEALTH CARE); RETROSPECTIVE STUDIES; RURAL HEALTH SERVICES; THROMBOLYTIC THERAPY; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 80052279146     PISSN: 10903127     EISSN: 15450066     Source Type: Journal    
DOI: 10.3109/10903127.2011.598609     Document Type: Article

References (31)

1. Boersma E, Mercado N, Poldermans D, Gardien M, Vos J, Simoons ML. Acute myocardial infarction. Lancet. 2003;361:847-58. (Pubitemid 36331851)
2. Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction; A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). J Am Coll Cardiol. 2004;44:E1-E211.
3. Nallamothu BK, Bates ER,Wang Y, Bradley EH, Krumholz HM. Driving times and distances to hospitals with percutaneous coronary intervention in the United States: implications for prehospital triage of patients with ST-elevation myocardial infarction. Circulation. 2006;113:1189-95.
4. Nallamothu BK, Bates ER. Percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction: is timing (almost) everything? Am J Cardiol. 2003;92:824-6. (Pubitemid 37163578)
5. Moser DK, Kimble LP, Alberts MJ, et al. Reducing delay in seeking treatment by patients with acute coronary syndrome and stroke: a scientific statement from the American Heart Association Council on Cardiovascular Nursing and Stroke Council. Circulation. 2006;114:168-82. (Pubitemid 44420749)
6. North Carolina State Center for Health Statistics. Leading causes of death in North Carolina. Available at: http://www. schs.state.nc.us/SCHS/data/ lcd/lcd.cfm. Accessed July 8, 2010.
7. Gilbert EH, Lowenstein SR, Koziol-McLain J, Barta DC, Steiner J. Chart reviews in emergency medicine research: where are the methods? Ann Emerg Med. 1996;27:305-8. (Pubitemid 26085005)
8. Nallamothu BK, Wang Y, Bradley EH, et al. Comparing hospital performance in door-to-balloon time between the Hospital Quality Alliance and the National Cardiovascular Data Registry. J Am Coll Cardiol. 2007;50:1517-9. (Pubitemid 47494589)
9. Taher T, Fu Y, Wagner GS, et al. Aborted myocardial infarction in patients with ST-segment elevation: insights from the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen-3 Trial Electrocardiographic Substudy. J Am Coll Cardiol. 2004;44:38-43. (Pubitemid 38968453)
10. Morrow DA, Antman EM, Sayah A, et al. Evaluation of the time saved by prehospital initiation of reteplase for ST-elevationmyocardial infarction: results of the Early Retavase-Thrombolysis in Myocardial Infarction (ER-TIMI) 19 trial. J Am Coll Cardiol. 2002;40:71-7. (Pubitemid 34701379)
11. Schroder R, Wegscheider K, Schroder K, Dissmann R, Meyer-Sabellek W. Extent of early ST segment elevation resolution: a strong predictor of outcome in patients with acute myocardial infarction and a sensitivemeasure to compare thrombolytic regimens. A substudy of the International Joint Efficacy Comparison of Thrombolytics (INJECT) trial. J Am Coll Cardiol. 1995;26:1657-64.
12. Diercks DB, Hollander JE. Catheterization laboratory activation: more about the drawing than the balloons. Ann Emerg Med. 2010;55:431-3.
13. Morrison LJ, Verbeek PR, McDonald AC, Sawadsky BV, Cook DJ. Mortality and prehospital thrombolysis for acute myocardial infarction: a meta-analysis. JAMA. 2000;283: 2686-92. (Pubitemid 30337331)
14. Sayah AJ, Roe MT. The role of fibrinolytics in the prehospital treatment of ST-elevation myocardial infarction (STEMI). J Emerg Med. 2008;34:405-16.
15. Castaigne AD, Herv́e C, Duval-Moulin AM, et al. Prehospital use of APSAC: results of a placebo-controlled study. Am J Cardiol. 1989;64:30A-33A. (Pubitemid 19169671)
16. Roth A, Barbash GI, HodH, et al. Should thrombolytic therapy be administered in the mobile intensive care unit in patients with evolving myocardial infarction? A pilot study. J Am Coll Cardiol. 1990;15:932-6. (Pubitemid 20104540)
17. Weaver WD, Cerqueira M, Hallstrom AP, et al. Prehospitalinitiated vs hospital-initiated thrombolytic therapy. The Myocardial Infarction Triage and Intervention Trial. JAMA. 1993;270:1211-6.
18. Cannon CP, Gibson CM, McCabe CH, et al. TNK-tissue plasminogen activator compared with front-loaded alteplase in acute myocardial infarction: results of the TIMI 10B trial. Thrombolysis in Myocardial Infarction (TIMI) 10B Investigators. Circulation. 1998;98:2805-14. (Pubitemid 29003960)
19. Murphy SA, Gibson CM, Van de Werf F, McCabe CH, Cannon CP. Comparison of errors in estimating weight and in dosing of single-bolus tenecteplase with tissue plasminogen activator (TIMI 10B and ASSENT I). Am J Cardiol. 2002;90:51-4. (Pubitemid 34671204)
20. Jackson L, Kendall J, Castle N. Does prehospital thrombolysis increase the proportion of patients who have an aborted myocardial infarction? Emerg Med J. 2009;26:206-9.
21. Lamfers EJ, Hooghoudt TE, Uppelschoten A, Stolwijk PW, Verheugt FW. Effect of prehospital thrombolysis on aborting acute myocardial infarction. Am J Cardiol. 1999;84:928-30. (Pubitemid 29475079)
22. Lamfers EJ, Hooghoudt TE, Hertzberger DP, Schut A, Stolwijk PW, Verheugt FW. Abortion of acute ST segment elevation myocardial infarction after reperfusion: incidence, patients' characteristics, and prognosis. Heart. 2003;89:496-501. (Pubitemid 36520795)
23. Lamfers EJ, Schut A, Hertzberger DP, et al. Prehospital versus hospital fibrinolytic therapy using automated versus cardiologist electrocardiographic diagnosis of myocardial infarction: abortion of myocardial infarction and unjustified fibrinolytic therapy. Am Heart J. 2004;147:509-15. (Pubitemid 38880875)
24. Eckstein M, Cooper E, Nguyen T, Pratt FD. Impact of paramedic transport with prehospital 12-lead electrocardiography on door-to-balloon times for patients with ST-segment elevation myocardial infarction. Prehosp Emerg Care. 2009;13: 203-6.
25. Eckstein M, Koenig W, Kaji A, Tadeo R. Implementation of specialty centers for patients with ST-segment elevation myocardial infarction. Prehosp Emerg Care. 2009;13:215-22.
26. Lee CH, Van Gelder CM, Cone DC. Early cardiac catheterization laboratory activation by paramedics for patients with STsegment elevation myocardial infarction on prehospital 12-lead electrocardiograms. Prehosp Emerg Care. 2010;14:153-8.
27. Welsh RC, Travers A, Senaratne M, Williams R, Armstrong PW. Feasibility and applicability of paramedic-based prehospital fibrinolysis in a large North American center. Am Heart J. 2006;152:1007-14. (Pubitemid 44856708)
28. Bjorklund E, Stenestrand U, Lindback J, Svensson L, Wallentin L, Lindahl B. Pre-hospital thrombolysis delivered by paramedics is associated with reduced time delay and mortality in ambulance-transported real-life patients with ST-elevation myocardial infarction. Eur Heart J. 2006;27: 1146-52.
29. Wallentin L, Goldstein P, Armstrong PW, et al. Efficacy and safety of tenecteplase in combination with the low-molecularweight heparin, enoxaparin, or unfractionated heparin in the prehospital setting: the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 PLUS randomized trial in acute myocardial infarction. Circulation. 2003;108: 135-42. (Pubitemid 36871293)
30. Luepker RV, Raczynski JM, Osganian S, et al. Effect of a community intervention on patient delay and emergency medical service use in acute coronary heart disease: the Rapid Early Action for Coronary Treatment (REACT) Trial. JAMA. 2000;284: 60-7. (Pubitemid 30445662)
31. Aufderheide TP, Keelan MH, Hendley GE, et al. Milwaukee Prehospital Chest Pain Project-phase I: feasibility and accuracy of prehospital thrombolytic candidate selection. Am J Cardiol. 1992;69:991-6. (Pubitemid 23058992)